Vlad Coric - 03 Feb 2026 Form 3 Insider Report for Veradermics, Inc (MANE)

Role
Director
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
MANE
Transactions as of
03 Feb 2026
Net transactions value
$0
Form type
3
Filing time
03 Feb 2026, 21:05:56 UTC
Previous filing
07 Jan 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coric Vlad Director C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN /s/ Michael Greco, Attorney-in-Fact 03 Feb 2026 0001704317

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MANE Common Stock 12,827 03 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MANE Series A Convertible Preferred Stock 03 Feb 2026 Common Stock 33,706 See Footnote F1, F2
holding MANE Series A Convertible Preferred Stock 03 Feb 2026 Common Stock 33,706 See Footnote F1, F3
holding MANE Series B Convertible Preferred Stock 03 Feb 2026 Common Stock 148,794 See Footnote F2, F4
holding MANE Series B Convertible Preferred Stock 03 Feb 2026 Common Stock 148,794 See Footnote F3, F4
holding MANE Series C Convertible Preferred Stock 03 Feb 2026 Common Stock 78,075 See Footnote F2, F5
holding MANE Series C Convertible Preferred Stock 03 Feb 2026 Common Stock 78,075 See Footnote F3, F5
holding MANE Series C Convertible Preferred Stock 03 Feb 2026 Common Stock 117,112 Direct F5
holding MANE Stock Option (Right to Buy) 03 Feb 2026 Common Stock 4,764 $12.19 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Convertible Preferred Stock is convertible into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis and has no expiration date. The Series A Convertible Preferred Stock will automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering.
F2 Shares held by Vladimir Coric Family Trust 2013.
F3 Shares held by Vladimir Coric Marital Trust 2013.
F4 Each share of Series B Convertible Preferred Stock is convertible into shares of the Issuer's Common Stock on a 10.067-for-1 basis and has no expiration date. The Series B Convertible Preferred Stock will automatically convert into Common Stock upon the closing of the Issuer's initial public offering.
F5 Each share of Series C Convertible Preferred Stock is convertible into shares of the Issuer's Common Stock on a 10.067-for-1 basis and has no expiration date. The Series C Convertible Preferred Stock will automatically convert into Common Stock upon the closing of the Company's initial public offering.
F6 The option is vested as to 25% of the underlying shares of Common Stock as of November 3, 2023, the first anniversary of the vesting commencement date, and vests as to the remaining shares in equal monthly installments over 36 months thereafter, subject to continued service.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney